when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

6,918 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Phase 2
rhenium (186Re) obisbemeda
Reyobiq (rhenium (186Re) obisbemeda)
Malignant Glioma$PSTV PLUS THERAPEUTICS, INC.
Marketed
rho(D) immune globulin (human)
RhoGAM (rho(D) immune globulin (human))
Erythroblastosis Fetalis (Hemolytic Disease In Newborns) Kedrion Biopharma Inc
Marketed
ribavirin
Ribavirin
Lower Respiratory Tract Infections Navinta LLC

page 213 of 231

Phase 2

Clostridioides difficile Infections (Clostridium difficil…

$TOVX Theriva Biologics, Inc.

pre_registration

Limb-Girdle Muscular Dystrophy ML Bio Solutions Inc

Marketed

ribociclib succinate

Kisqali (ribociclib succinate)

Human Epidermal Growth Factor Receptor 2 Negative Breast…$NVS NOVARTIS AG

Phase 3

ribupatide [INN]

Obesity$KLRA Kailera Therapeutics, Inc.

Marketed

Mycobacterium avium Infections i3 Pharmaceuticals LLC

Phase 2

Proctitis Cosmo Pharmaceuticals NV

Phase 2

rifaquizinone [INN]

Prosthetic Joint infections Tennor Therapeutics (Suzhou) Co., Ltd.

Marketed

Xifaxan (rifaximin)

Hepatic Encephalopathy Salix Pharmaceuticals Ltd

Phase 2

rigosertib sodium

rigosertib sodium

Non-Small Cell Lung Cancer$TRAW Traws Pharma, Inc.

Phase 3

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)$SNY Sanofi

Phase 1

Cancer Anorexia-Cachexia Syndrome AVEO Pharmaceuticals Inc

Phase 3

Chronic Kidney Disease (Chronic Renal Failure)$PROK PROKIDNEY CORP.

Marketed

Riluzole Rising (riluzole)

Amyotrophic Lateral Sclerosis Rising Pharma Holdings Inc

Marketed

Wayrilz (rilzabrutinib)

Acquired (Autoimmune) Hemolytic Anemia$SNY Sanofi

Marketed

rimabotulinumtoxinB

Myobloc (rimabotulinumtoxinB)

Spasmodic Torticollis (Cervical Dystonia)$SUPN SUPERNUS PHARMACEUTICALS, INC.

Marketed

rimantadine hydrochloride

Rimantadine Hydrochloride

Influenzavirus A Infections$AMRX Amneal Pharmaceuticals, Inc.

Phase 3

rinatabart sesutecan

rinatabart sesutecan

Epithelial Ovarian Cancer Genmab AS

Phase 2

Ampligen (rintatolimod)

Epithelial Ovarian Cancer$AIM AIM ImmunoTech Inc.

Phase 3

rinvecalinase alfa

rinvecalinase alfa

Acute Ischemic Stroke$DMAC DiaMedica Therapeutics Inc.

Phase 1

rinzimetostat [INN]

Metastatic Castration-Resistant Prostate Cancer (mCRPC)$ORIC Oric Pharmaceuticals, Inc.

Marketed

Adempas (riociguat)

Chronic Thromboembolic Pulmonary Hypertension Bayer HealthCare Pharmaceuticals Inc

Phase 3

ripasudil hydrochloride

ripasudil hydrochloride

Fuchs Endothelial Corneal Dystrophy (FECD) Kowa Co Ltd

Marketed

Qinlock (ripretinib)

Gastrointestinal Stromal Tumor (GIST) Deciphera Pharmaceuticals Inc

Marketed

risedronate sodium

Actonel (risedronate sodium)

Glucocorticoid-Induced Osteoporosis Allergan Finance LLC

Marketed

risperidone ODT

Bipolar Disorder (Manic Depression) Senores Pharmaceuticals Inc

Phase 2

ristoglogene autogetemcel

ristoglogene autogetemcel [INN]

Beta Thalassaemia$BEAM Beam Therapeutics Inc.

Phase 2

Luminate (risuteganib)

Dry (Atrophic) Macular Degeneration Allegro Ophthalmics LLC